Citations

1. Ringel Y, et al. (2001). Irritable bowel syndrome. Annual Review of Medicine, 52: 319–338.

2. Read NW (2002). Irritable bowel syndrome. In M Feldman et al., eds., Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 7th ed., vol. 2, pp. 1794–1806. Philadelphia: W.B. Saunders.

3. Mertz HR (2003). Irritable bowel syndrome. New England Journal of Medicine, 349(22): 2136–2146.

4. Thompson WG, et al. (2000). Irritable bowel syndrome section of Functional bowel disorders and functional abdominal pain. In DA Drossman et al., eds., Rome II: The Functional Gastrointestinal Disorders, 2nd ed., pp. 355–375. McLean, VA: Degnon Associates.

5. Thompson WG, et al. (1999). Functional bowel disorders and functional abdominal pain. Gut, 45(Suppl II): II43–II47.

6. American College of Gastroenterology Functional Gastrointestinal Disorders Task Force (2002). Evidence-based position statement on the management of irritable bowel syndrome in North America. American Journal of Gastroenterology, 97(11, Suppl): S1–S26.

7. Olden KW (2002). Diagnosis of irritable bowel syndrome. Gastroenterology, 122(6): 1701–1714.

8. Holten KB, Wetherington A (2003). Diagnosing the patient with abdominal pain and altered bowel habits: Is it irritable bowel syndrome? American Family Physician, 67(10): 2157–2162.

9. Hasler WL (2002). The irritable bowel syndrome. Medical Clinics of North America, 86: 1525–1551.

10. American Gastroenterological Association (2002). American Gastroenterological Association medical position statement: Irritable bowel syndrome. Gastroenterology, 123(6): 2105–2107.

11. Talley NJ (2000). Treatment of the irritable bowel syndrome. In MM Wolfe et al., eds., Sleisenger and Fordtran's Therapy of Digestive Disorders, pp. 477–490. Philadelphia: W.B. Saunders.

12. Spanier JA, et al., (2003). A systematic review of alternative therapies in the irritable bowel syndrome. Archives of Internal Medicine, 163: 265–274.

13. Marteau PR, et al. (2001). Protection from gastrointestinal diseases with the use of probiotics. American Journal of Clinical Nutrition, 73(2, Suppl 1): 430S–436S.

14. Sharara AI, et al. (2006). A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. American Journal of Gastroenterology, 101(2): 326–333.

Other Works Consulted

• American Gastroenterological Association (2002). American Gastroenterological Association medical position statement: Irritable bowel syndrome. Gastroenterology, 123(6): 2105–2107.

• Friedel D, et. al. (2001). Ischemic colitis during treatment with alosetron. Gastroenterology, 120(2): 557–560.